Oblimersen in combination with temozolomide and albumin-bound paclitaxel in patients with advanced melanoma: a phase I trial.

Oblimersen in combination with temozolomide and albumin-bound paclitaxel in patients with advanced melanoma: a phase I trial.

Item
http://www.wikidata.org/entity/Q33403800
Targeting BCL2-Proteins for the Treatment of Solid TumoursDrug delivery nanoparticles in skin cancersClinical Translation of Nanomedicine.Nuclear localization signal domain of HDAC3 is necessary and sufficient for the expression regulation of MDR1.miR-326-histone deacetylase-3 feedback loop regulates the invasion and tumorigenic and angiogenic response to anti-cancer drugs.Novel anti-melanoma treatment: focus on immunotherapy.Adenovirus-mediated FKHRL1/TM sensitizes melanoma cells to apoptosis induced by temozolomide.Phosphorothioate backbone modifications of nucleotide-based drugs are potent platelet activators.Noninvasive approach for enhancing small interfering RNA delivery percutaneously.Tubulin Beta3 Serves as a Target of HDAC3 and Mediates Resistance to Microtubule-Targeting Drugs.c-Myc modulation: a key role in melanoma drug response.A Polyethylenimine-Containing and Transferrin-Conjugated Lipid Nanoparticle System for Antisense Oligonucleotide Delivery to AML.Nanoparticle albumin bound Paclitaxel in the treatment of human cancer: nanodelivery reaches prime-time?The synergic antitumor effects of paclitaxel and temozolomide co-loaded in mPEG-PLGA nanoparticles on glioblastoma cells.Applications of nanotechnology for melanoma treatment, diagnosis, and theranostics.Discontinued drugs for pulmonary, allergy, gastrointestinal, arthritis (2012).Antisense therapeutics in oncology: current status.
P2860

Oblimersen in combination with temozolomide and albumin-bound paclitaxel in patients with advanced melanoma: a phase I trial.

Item
http://www.wikidata.org/entity/Q33403800
description
2012 nî lūn-bûn
@nan
2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Oblimersen in combination with ...... ced melanoma: a phase I trial.
@ast
Oblimersen in combination with ...... ced melanoma: a phase I trial.
@en
type
label
Oblimersen in combination with ...... ced melanoma: a phase I trial.
@ast
Oblimersen in combination with ...... ced melanoma: a phase I trial.
@en
prefLabel
Oblimersen in combination with ...... ced melanoma: a phase I trial.
@ast
Oblimersen in combination with ...... ced melanoma: a phase I trial.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P6179
P698
P921
P356
P1433
P1476
Oblimersen in combination with ...... ced melanoma: a phase I trial.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P6179
P698
P921